Malignant melanoma detected during follow-up: literature review and cases report


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The article discusses the possibility of timely diagnosis of malignant melanoma by assessing changes in the dermatoscopic picture of formations during follow-up. An analysis of 23 cases from authors’ own practice, identified mainly in patients at risk, is given. The age of the patients varied from 28 to 70 years, mean age 36.7±10.5 years. Follow-up of pigmented lesions before making a decision on excision was performed out for 3-24 months, on average - 10.5±5.4 months. Changes in the dermatoscopic picture were manifested by an asymmetric increase of the lesion and/or a change of its shape (43.5%), the appearance of a new color (69.6%), the formation of an atypical dermatoscopic structure (65.2%), a change in the pattern of the pigment network (56.5 %), modification of the dermatoscopic model of the structure (21.7%), partial regression of formation (4.3%). The mean diameter of the lesions during the follow-up period increased from 4.2±2.2 to 5.4±2.3 mm, the lesion value of the total dermoscopic score of the ABCD rule increased from 3.4±0.9 to 4.6±1.2 points (P<0.05). Histological examination diagnosed melanoma in situ in 52.2% of cases, in the rest - microinvasive melanoma (Clark level II) with Breslow thickness range from 0.2 to 0.5 mm.

全文:

受限制的访问

作者简介

Yuri Sergeev

Society of Dermatoscopy and Optical Diagnostics of the Skin; Central State Medical Academy of Department of Presidential Affairs

Email: tosergeev@gmail.com

D. Beinusov

Society of Dermatoscopy and Optical Diagnostics of the Skin

V. Mordovtseva

Society of Dermatoscopy and Optical Diagnostics of the Skin; Moscow State University of Food Production

V. Sergeev

Society of Dermatoscopy and Optical Diagnostics of the Skin; Central State Medical Academy of Department of Presidential Affairs

参考

  1. Kittler H., Pehamberger H., Wolff K., Binder M. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J. Am Acad Dermatol. 2000;43(3):467-76. Doi: 10.1067/ mjd.2000.107504.
  2. Menzies S.W., Gutenev A., Avramidis M., et al. Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch Dermatol. 2001;137(12):1583-89. doi: 10.1001/archderm.137.12.1583.
  3. Malvehy J., Puig S. Follow-up of melanocytic skin lesions with digital total-body photography and digital dermoscopy: a two-step method. Clin Dermatol. 2002;20(3):297- 304. Doi: 10.1016/ s0738-081x(02)00220-1.
  4. Robinson J.K., Nickoloff B.J. Digital epiluminescence microscopy monitoring of high-risk patients. Arch Dermatol. 2004;140(1):49-56. Doi: 10.1001/ archderm.140.1.49.
  5. Bauer J., Blum A., Strohhacker U., Garbe C. Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy. Br J. Dermatol. 2005;152(1):87- 92. doi: 10.1111/j.1365-2133.2005.06370.x.
  6. Fuller S.R., Bowen G.M., Tanner B., et al. Digital dermoscopic monitoring of atypical nevi in patients at risk for melanoma. Dermatol Surg. 2007;33(10):1198-206. doi: 10.1111/j.1524-4725.2007.33254.x.
  7. Altamura D., Avramidis M., Menzies S.W. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma. Arch Dermatol. 2008;144(4):502-6. doi: 10.1001/archderm.144.4.502.
  8. Flaenssle H.A., Korpas B., Hansen-Hagge C. et al. Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors. Arch Dermatol. 2010;146(3):257-64. doi: 10.1001/archdermatol.2009.370.
  9. Argenziano G., Mordente I., Ferrara G., et al. Dermoscopicmonitoring of melanocytic skin lesions: clinical outcome and patient compliance varyaccording to follow-up protocols. Br J. Dermatol. 2008;159(2):331-36. doi: 10.1111/j.1365-2133.2008.08649.x.
  10. Argenziano G., Kittler H., Ferrara G., et al. Slow-growing melanoma: a dermoscopy follow-up study. Br. J. Dermatol. 2010; (2): 267-73. doi: 10.1111/j.1365-2133.2009.09416.x.
  11. Salerni G., Carrera C., Lovatto L., et al. Characterization of 1152 lesions excised over 10 years using total-body photography and digital dermatoscopy in the surveillance of patients at high risk for melanoma. J. Am Acad Dermatol. 2012;67(5):836-45. Doi: 10.1016/j. jaad.2012.01.028.
  12. Fikrle T., Pizinger K., Szakos H., et al. Digital dermatoscopic follow-up of 1027 melanocytic lesions in 121 patients at risk of malignant melanoma. J. Eur Acad Dermatol Venereol. 2013;27(2):180-86. doi: 10.1111/j.1468- 3083.2011.04438.x.
  13. Ungureanu L., Letca A., Senila S.C., et al. Patterns of change during the dermoscopic follow-up of melanocytic lesions in high risk patients. Clujul Med. 2015;88(1):38-43. Doi: 10.15386/ cjmed-394.
  14. Rinner C., Tschandl P., Sinz C., Kittler H. Long-term evaluation of the efficacy of digital dermatoscopy monitoring at a tertiary referral center. J. Dtsch Dermatol Ges. 2017;15(5):517-22. doi: 10.1111/ddg.13237.
  15. Moscarella E., Tion I., Zalaudek I., et al. Both short-term and long-term dermoscopy monitoring is useful in detecting melanoma in patients with multiple atypical nevi. J. Eur Acad Dermatol Venereol. 2017;31(2):247-51. Doi: 10.1111/ jdv. 13840.
  16. Pampena R., Manfreda V., Kyrgidis A., et al. et al. Digital dermoscopic changes during follow-up of de-novo and nevus-associated melanoma: a cohort study Int J. Dermatol. 2020;59(7):813-21. doi: 10.1111/ijd.14918.
  17. Saura S.P., March-Rodriguez A., Pujol R.M., et al. Two-step digital follow-up of patients at high risk for melanoma: a retrospective analysis of 152 patients. Actas Dermosifiliogr. 2021;112(3):250-56. doi: 10.1016/j.ad.2020.11.004.
  18. Сергеев Ю.Ю., Мордовцева В.В. Опыт диагностики меланомы кожи диаметром менее 6 мм. Клиническая дерматология и венерология. 2018;17(4):97-105. Doi: 10.17116/ klinderma20181704197.
  19. Сергеев Ю.Ю., Сергеев В.Ю., Мордовцева В.В. и др. Меланома кожи в 2019 г: особенности клинической и дерматоскопической картины опухоли на современном этапе. Фарматека. 2020;27(8):28-35. doi: 10.18565/pharmateca.2020.8.28-35.
  20. Geller A.C., Greinert R., Sinclair C., et al. A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009). Cancer Epidemiol. 2010;34(3):355-58. doi: 10.1016/j.canep.2010.03.006.
  21. US Preventive Services Task Force, Bibbins-Domingo K., Grossman D.C., Curry S.J., et al. Screening for skin cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;316(4):429-35. Doi: 10.1001/ jama.2016.8465.
  22. Collins M.K., Secrest A.M., Ferris L.K. Screening for melanoma. Melanoma Res. 2014;24(5):428-36. doi: 10.1097/CMR.0000000000000104.
  23. Сергеев Ю.Ю., Сергеев В.Ю., Мордовцева В.В. Динамическое наблюдение за меланоцитарными образованиями при помощи дерматоскопии (обзор литературы). Медицинский алфавит. Серия «Дерматология». 2020;1.6(420):66-71.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2021
##common.cookie##